eGMD - Epigenetics in Metabolic Diseases // 3rd LIMIOR - Leipzig International Meeting for Interdisciplinary Obesity Research taking place from 11 to 13 December 2019
Metabolic diseases such as obesity and type 2 diabetes are of a complex nature making the identification of factors driving the development and progression a huge challenge. During the past two decades, big genome wide studies successfully identified genes involved in the pathophysiology of metabolic diseases. However, only a small proportion of the heritability can be explained so far. Therefore focusing on additional factors such as epigenetics and the environmental impact helps to unwind the complexity and opens the view on mechanisms and pathways. But most importantly understanding of how these factors interact and contribute to the pathophysiology of metabolic diseases, the eGMD is meant to learn and discuss following questions: Beside the genetic risk, what can we learn from the genetic architecture, non-coding factors and epigenetic modifications in obesity and related diseases? How are environmental factors involved in gene regulation? And how can we translate this knowledge into diagnosis, prognosis up to prevention and treatment strategies? Having an exclusive list of renowned speakers, the eGMD aims to bring cutting edge knowledge together and especially invites young enthusiastic scientists to join this meeting and aim for fruitful discussions.
More information concerning speakers, registration etc. coming soon!